These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
303 related articles for article (PubMed ID: 24509440)
1. The role of vascular-derived perlecan in modulating cell adhesion, proliferation and growth factor signaling. Lord MS; Chuang CY; Melrose J; Davies MJ; Iozzo RV; Whitelock JM Matrix Biol; 2014 Apr; 35():112-22. PubMed ID: 24509440 [TBL] [Abstract][Full Text] [Related]
2. Perlecan inhibits smooth muscle cell adhesion to fibronectin: role of heparan sulfate. Lundmark K; Tran PK; Kinsella MG; Clowes AW; Wight TN; Hedin U J Cell Physiol; 2001 Jul; 188(1):67-74. PubMed ID: 11382923 [TBL] [Abstract][Full Text] [Related]
3. Pathogenesis of abdominal aortic aneurysms: possible role of differential production of proteoglycans by smooth muscle cells. Melrose J; Whitelock J; Xu Q; Ghosh P J Vasc Surg; 1998 Oct; 28(4):676-86. PubMed ID: 9786264 [TBL] [Abstract][Full Text] [Related]
4. Heparan and chondroitin sulfate on growth plate perlecan mediate binding and delivery of FGF-2 to FGF receptors. Smith SM; West LA; Govindraj P; Zhang X; Ornitz DM; Hassell JR Matrix Biol; 2007 Apr; 26(3):175-84. PubMed ID: 17169545 [TBL] [Abstract][Full Text] [Related]
5. Perlecan heparan sulfate deficiency impairs pulmonary vascular development and attenuates hypoxic pulmonary hypertension. Chang YT; Tseng CN; Tannenberg P; Eriksson L; Yuan K; de Jesus Perez VA; Lundberg J; Lengquist M; Botusan IR; Catrina SB; Tran PK; Hedin U; Tran-Lundmark K Cardiovasc Res; 2015 Jul; 107(1):20-31. PubMed ID: 25952902 [TBL] [Abstract][Full Text] [Related]
6. Heparan sulfate side chains have a critical role in the inhibitory effects of perlecan on vascular smooth muscle cell response to arterial injury. Gotha L; Lim SY; Osherov AB; Wolff R; Qiang B; Erlich I; Nili N; Pillarisetti S; Chang YT; Tran PK; Tryggvason K; Hedin U; Tran-Lundmark K; Advani SL; Gilbert RE; Strauss BH Am J Physiol Heart Circ Physiol; 2014 Aug; 307(3):H337-45. PubMed ID: 24858854 [TBL] [Abstract][Full Text] [Related]
7. Lead inhibits the core protein synthesis of a large heparan sulfate proteoglycan perlecan by proliferating vascular endothelial cells in culture. Fujiwara Y; Kaji T Toxicology; 1999 Apr; 133(2-3):159-69. PubMed ID: 10378482 [TBL] [Abstract][Full Text] [Related]
8. Human perlecan immunopurified from different endothelial cell sources has different adhesive properties for vascular cells. Whitelock JM; Graham LD; Melrose J; Murdoch AD; Iozzo RV; Underwood PA Matrix Biol; 1999 Apr; 18(2):163-78. PubMed ID: 10372557 [TBL] [Abstract][Full Text] [Related]
9. Removal of heparan sulfate by heparinase treatment inhibits FGF-2-dependent smooth muscle cell proliferation in injured rat carotid arteries. Kinsella MG; Irvin C; Reidy MA; Wight TN Atherosclerosis; 2004 Jul; 175(1):51-7. PubMed ID: 15186946 [TBL] [Abstract][Full Text] [Related]
10. Myeloperoxidase-derived oxidants selectively disrupt the protein core of the heparan sulfate proteoglycan perlecan. Rees MD; Whitelock JM; Malle E; Chuang CY; Iozzo RV; Nilasaroya A; Davies MJ Matrix Biol; 2010 Jan; 29(1):63-73. PubMed ID: 19788922 [TBL] [Abstract][Full Text] [Related]
11. Peroxynitrite modifies the structure and function of the extracellular matrix proteoglycan perlecan by reaction with both the protein core and the heparan sulfate chains. Kennett EC; Rees MD; Malle E; Hammer A; Whitelock JM; Davies MJ Free Radic Biol Med; 2010 Jul; 49(2):282-93. PubMed ID: 20416372 [TBL] [Abstract][Full Text] [Related]
12. Platelet Factor 4 Binds to Vascular Proteoglycans and Controls Both Growth Factor Activities and Platelet Activation. Lord MS; Cheng B; Farrugia BL; McCarthy S; Whitelock JM J Biol Chem; 2017 Mar; 292(10):4054-4063. PubMed ID: 28115521 [TBL] [Abstract][Full Text] [Related]
13. Induction of synthesis of a large heparan sulfate proteoglycan, perlecan, by thrombin in cultured human coronary smooth muscle cells. Yamamoto C; Wakata T; Fujiwara Y; Kaji T Biochim Biophys Acta; 2005 Feb; 1722(1):92-102. PubMed ID: 15716125 [TBL] [Abstract][Full Text] [Related]
14. Heparan sulfate-dependent signaling of fibroblast growth factor 18 by chondrocyte-derived perlecan. Chuang CY; Lord MS; Melrose J; Rees MD; Knox SM; Freeman C; Iozzo RV; Whitelock JM Biochemistry; 2010 Jul; 49(26):5524-32. PubMed ID: 20507176 [TBL] [Abstract][Full Text] [Related]
15. Differential binding of vascular cell-derived proteoglycans (perlecan, biglycan, decorin, and versican) to the beta-amyloid protein of Alzheimer's disease. Snow AD; Kinsella MG; Parks E; Sekiguchi RT; Miller JD; Kimata K; Wight TN Arch Biochem Biophys; 1995 Jun; 320(1):84-95. PubMed ID: 7793988 [TBL] [Abstract][Full Text] [Related]
16. Endorepellin causes endothelial cell disassembly of actin cytoskeleton and focal adhesions through alpha2beta1 integrin. Bix G; Fu J; Gonzalez EM; Macro L; Barker A; Campbell S; Zutter MM; Santoro SA; Kim JK; Höök M; Reed CC; Iozzo RV J Cell Biol; 2004 Jul; 166(1):97-109. PubMed ID: 15240572 [TBL] [Abstract][Full Text] [Related]
17. Lipoprotein modulation of subendothelial heparan sulfate proteoglycans (perlecan) and atherogenicity. Pillarisetti S Trends Cardiovasc Med; 2000 Feb; 10(2):60-5. PubMed ID: 11150731 [TBL] [Abstract][Full Text] [Related]
18. Heparan sulfate proteoglycans function as receptors for fibroblast growth factor-2 activation of extracellular signal-regulated kinases 1 and 2. Chua CC; Rahimi N; Forsten-Williams K; Nugent MA Circ Res; 2004 Feb; 94(3):316-23. PubMed ID: 14684627 [TBL] [Abstract][Full Text] [Related]
19. Endothelial cells interact with the core protein of basement membrane perlecan through beta 1 and beta 3 integrins: an adhesion modulated by glycosaminoglycan. Hayashi K; Madri JA; Yurchenco PD J Cell Biol; 1992 Nov; 119(4):945-59. PubMed ID: 1385448 [TBL] [Abstract][Full Text] [Related]
20. Perlecan is responsible for thrombospondin 1 binding on the cell surface of cultured porcine endothelial cells. Vischer P; Feitsma K; Schön P; Völker W Eur J Cell Biol; 1997 Aug; 73(4):332-43. PubMed ID: 9270876 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]